USFDA


  • Jan
    30
    By PTI

    Drug firm Lupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in treating diabetes.

    The company's US-based subsidiary Lupin

  • Jan
    27
    By PTI

    Drug firm Dr Reddy's Laboratories on Friday said it has resolved all issues raised by a division of US health regulator over its promotional material for an anti-coagulant injection.
    On

  • Jan
    10
    By PTI

    Drug firm Wockhardt today said it has received final approval from the US health regulator to market generic Fluticasone nasal spray, used for treating allergic nasal inflammation, in the American

  • Dec
    22
    By Kumar Shankar Roy

    The US Food and Drug Administration (USFDA), may re-inspect Dr Reddy’s Laboratories’ (DRL) Mexico plant by June 2012.
    The unit received a four-item warning letter in June 2011.

  • Oct
    11
    By PTI

    Drug firm Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic Gabapentin tablets, used in the treatment of central nervous

  • Sep
    30
    By PTI

    Drug firm Strides Arcolab today said its subsidiary Onco Therapies has received approval from the US health regulator USFDA to market generic Paclitaxel injection, used for treating cancers, in the

  • Sep
    19
    By PTI

    Sun Pharmaceutical Industries Ltd today said its US arm has resolved issues raised by the country's health regulator regarding violation of manufacturing standards.

    "The US Food and Drug Administration (USFDA)

  • Aug
    04
    By PTI

    Glenmark Pharmaceuticals today said its subsidiary Glenmark Generics Inc has received final approval from the US health regulator for Verapamil tablets, which are used for treating hypertension.

    "Today's approval completes